Table 2.
Therapy | Sample [study reference] | Study Design | Sample Size |
Outcome Measures | Results of Therapy |
---|---|---|---|---|---|
Lingual Resistance | Older healthy adults [24] | Prospective cohort with intervention | 10 | Lingual pressures during swallowing and maximum tongue push task, swallow timing and bolus flow measures, lingual MRI (4 subjects only) | Lingual pressures (swallow and maximum) increased post therapy, swallow measures did not improve, lingual volume increased (MRI) |
Stroke patients [20] | Prospective Cohort with intervention | 10 | Lingual pressures during swallowing and maximum tongue push task, swallow timing and bolus measures, lingual MRI (3 subjects only), quality of life and dietary intake | Lingual pressures (swallow and maximum) increased post therapy, mixed results regarding reduced post swallow residue and penetration/aspiration (only for some materials), few changes in swallow timing measures, two of three subjects increased lingual volume | |
Progressive disease [25] | Case report | 1 | Lingual pressure during maximum push task, penetration/aspiration scores, residue | Posterior lingual pressure and penetration/aspiration scores maintained over course of study, no change in residue | |
Head / Neck cancer [26] | RCT Comparing Lingual exercise plus traditional therapy vs traditional therapy along | 23 | Tongue strength (maximum pressure), OPSE, salivary flow, quality of life | No change in tongue strength or OPSE, no significant differences in quality of life | |
Head Lift | Older healthy adults [21] | Age-matched with Random Assignment to sham vs. head lift | 31 | UES opening, Hyolaryngeal excursion, pharyngeal swallowing pressures | Increased UES opening, increased anterior laryngeal excursion, reduced pharyngeal swallowing pressures |
Pharyngeal dysphagia [22] | Cross over design | 27 | Swallow function, UES opening, Hyolaryngeal excursion, aspiration | Improved swallow function, increased UES opening, reduced aspiration | |
Older healthy adults [27] | Pre/Post comparison | 2 | sEMG evaluation of muscle fatigue | Initial fatigue in SCM with Subsequent strengthening, increase strength in supra/infrahyoid muscles | |
Head/Neck cancer and stroke [28] | Pre/Post Comparison with random assignment to traditional therapy vs. head lift | 11 | Thyrohyoid shortening during swallow | Post therapy Thyrohyoid shortening was greater in head lift subgroup | |
Older healthy adults [29] | Prospective cohort with intervention | 26 | adherence to exercise program | 50% to 70% adherence | |
MDTP | Chronic Pharyngeal dysphagia: Head/Neck Cancer and Stroke [23,30,31, 32] | Case series [23,32] | 9 [23] 6 [32] |
Clinical and functional change in swallowing, patient perception of swallowing, hyolaryngeal excursion, lingual swallowing pressure, pharyngeal swallowing pressure, sEMG amplitude during swallowing | Clinical and Functional swallowing, and patient perception scores improved significantly, increased hyolaryngeal excursion, increased lingual pressure and sEMG amplitude for pudding swallows, after treatment |
Parallel arm Comparison (patients with dysphagia vs. healthy controls) [31] | 42 (8 patients and 34 controls) | Timing of Physiologic pressure points during swallowing | Physiologic timing of swallow events improved following therapy becoming equivalent to healthy controls, effect most noted for thin liquids | ||
Case-Control : MDTP vs. Traditional therapy plus sEMG biofeedback[30] | 24 (8 cases and 16 controls) | Clinical and functional change in swallowing, presence of feeding post therapy, presence of aspiration post therapy | Enhanced clinical and functional outcomes, greater feeding tube removal, greater aspiration reduction, following MDTP | ||
Stroke (subacute rehabilitation) [33] | RCT (MDTP with sham TES, MDTP with motor level TES, traditional therapy | 53 | Clinical and Functional swallowing ability, change in body weight, dysphagia-related complications, return to pre-stroke diet, patient perception of swallow, proportion of treatment responders | Clinical and Functional measures of swallowing, proportion of treatment responders and number returning to pre-stroke diet significantly improved for the sham arm (MDTP) greater than experimental (MDTP + TES) or control arms (traditional therapy). | |
Pharyngocise | Head/Neck cancer treated during chemoradiotherapy [6,34] | RCT: Pharyngocise vs. usual care [6] | 58 [6] | Lingual, Suprahyoid muscle size and composition – measured by MRI, Functional swallowing ability, mouth opening, taste/smell function, salivation, nutritional status, occurrence of dysphagia – related complications. | Pharyngocise Group Demonstrated superior muscle preservation, functional swallowing, mouth opening, taste and salivation. |
RCT: Therapist Directed Pharyngocise vs. Patient directed Pharyngocise vs. usual care (control) [34] | 130 [34] | Maintenance of swallow muscle composition (MRI), functional swallowing ability, mouth opening, psycho-social adaptation, exercise compliance. | Less swallow Muscle deterioration, less functional swallow change and greater compliance identified in the therapist directed arm compared to patient directed or control |
MRI: magnetic resonance imaging; RCT: randomized controlled trial; OPSE: oropharyngeal swallow efficiency; UES: upper esophageal sphincter; sEMG: surface electromyography; SCM: sternocleidomastoid; MDTP: McNeill Dysphagia Therapy Program; TES: transcutaneous electrical stimulation